Okay, let's tackle this question. The user is asking about non-selective serotonin and noradrenaline reuptake inhibitors. So, first, I need to recall the different types of SNRIs and SSRIs. The key here is the term "non-selective," which means the drug inhibits both serotonin and norepinephrine reuptake without being specific to one.

Wait, the options aren't provided, but the correct answer is missing. The user probably wants me to generate the correct answer and explanation. Let me think of common SNRIs. Venlafaxine is a well-known SNRI. It inhibits both serotonin and norepinephrine reuptake. Then there's duloxetine, milnacipran, etc. But I need to be careful about selectivity. For example, some SNRIs might be more selective at higher doses but non-selective at lower ones. Venlafaxine is considered non-selective at standard doses.

Now, the core concept here is that SNRIs block the reuptake of both neurotransmitters, increasing their levels in the synaptic cleft. The correct answer would be a drug that does this without selectivity. Let me check the incorrect options. SSRIs like fluoxetine only inhibit serotonin. Tricyclic antidepressants (TCAs) like amitriptyline also inhibit both, but they have more anticholinergic effects. However, the question is about SNRIs, not TCAs. So if the options include TCAs, they might be distractors. Another possibility is that the options include a selective serotonin reuptake inhibitor, which would be incorrect here.

So, the correct answer is likely venlafaxine. The explanation should highlight that venlafaxine inhibits both reuptake mechanisms. The wrong options would be SSRIs or TCAs. The clinical pearl here is to remember that SNRIs like venlafaxine are used for depression and anxiety, whereas TCAs are older with more side effects.

**Core Concept**
Non-selective serotonin-norepinephrine reuptake inhibitors (SNRIs) block the reuptake of both **serotonin (5-HT)** and **norepinephrine (NE)** by inhibiting the **serotonin transporter (SERT)** and **norepinephrine transporter (NET)**. This dual inhibition increases synaptic concentrations of both neurotransmitters, enhancing mood regulation.

**Why the Correct Answer is Right**
Venlafaxine is a prototypical non-selective SNRI. At therapeutic doses, it **equally inhibits SERT and NET**, increasing synaptic 5-HT and NE levels. This mechanism underlies its efficacy in major depressive disorder and generalized anxiety disorder. Unlike selective SNRIs (e.g., duloxetine), venlafaxine lacks selectivity for one transporter over the other at standard doses.

**Why Each Wrong Option is Incorrect**
**Option A:** Fluoxetine is a selective serotonin reuptake inhibitor (SSRI), only inhibiting SERT.
**Option B:** Amitriptyline is a tricyclic antidepressant (TCA) that inhibits 5-HT and NE reuptake but also has significant anticholinergic and antihistaminergic effects, making it distinct from SNRIs.
**Option D:** Bupropion is

✓ Correct Answer: C. Venlafaxine